Next Generation Bispecifics in Solid Tumors
PharmaTalkRadio2 Nov 2020

Next Generation Bispecifics in Solid Tumors

In this podcast, you will hear a panel discussion moderated by Dr Priti Hegde, Foundation Medicine, from the 2020 IO360° Summit regarding next generation bispecifics in solid tumors. Discussion questions include: What is happening in hematology bispecific programs compared to solid tumor bispecific programs?What do bispecifics look like in solid tumors and what is driving efficacy?What’s hindering efficacy in solid tumors compared to hematology?How can we improve on it?What should we be doing on the next generation bispecifics? Panelists: Julie Bailis, PhD, Amgen Dimitris Skokos, PhD, Regeneron Pharmaceuticals David Schaer, PhD, Pfizer Pablo Umaña, PhD, Roche To learn more about the 2021 IO360° Summit, please visit www.io360summit.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
angestpodden
rss-ronden
rss-ai-med-jonas-benjamin
kapitalet-en-podd-om-ekonomi
rss-kriminologerna
halsorevolutionen
sexet
rss-ufobortom-rimligt-tvivel
det-morka-psyket
bildningspodden
rss-vetenskapsradion-2
medicinvetarna
rss-mottagningen
4health-med-anna-sparre
rss-vetenskapsradion
rss-experimentet
svd-nyhetsartiklar